Current and historical daily PE Ratio for Concord Drugs Ltd (
) from 2015 to May 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Concord Drugs stock (BOM:538965) PE ratio as of May 21 2024 is 38.33.
More Details
Concord Drugs Ltd (BOM:538965) PE Ratio (TTM) Chart
Concord Drugs Ltd (BOM:538965) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1224
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Concord Drugs PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-21 | 38.3 | 2024-03-07 | 39.1 |
| 2024-05-17 | 38.3 | 2024-03-06 | 38.4 |
| 2024-05-16 | 37.4 | 2024-03-05 | 39.7 |
| 2024-05-15 | 36.2 | 2024-03-04 | 39.2 |
| 2024-05-14 | 35.4 | 2024-03-01 | 39.3 |
| 2024-05-13 | 36.1 | 2024-02-29 | 39.2 |
| 2024-05-10 | 35.6 | 2024-02-28 | 38.8 |
| 2024-05-09 | 35.5 | 2024-02-27 | 39.2 |
| 2024-05-08 | 35.1 | 2024-02-26 | 39.6 |
| 2024-05-07 | 35.5 | 2024-02-23 | 40.4 |
| 2024-05-06 | 36.4 | 2024-02-22 | 40.4 |
| 2024-05-03 | 36.9 | 2024-02-21 | 39.8 |
| 2024-05-02 | 36.7 | 2024-02-20 | 39.7 |
| 2024-04-30 | 37.1 | 2024-02-19 | 39.5 |
| 2024-04-29 | 37.2 | 2024-02-16 | 40.0 |
| 2024-04-26 | 36.3 | 2024-02-15 | 41.4 |
| 2024-04-25 | 36.5 | 2024-02-14 | 43.4 |
| 2024-04-24 | 36.8 | 2024-02-13 | 42.9 |
| 2024-04-23 | 36.6 | 2024-02-12 | 44.6 |
| 2024-04-22 | 36.6 | 2024-02-09 | 46.2 |
| 2024-04-19 | 36.1 | 2024-02-08 | 45.5 |
| 2024-04-18 | 36.2 | 2024-02-07 | 46.4 |
| 2024-04-16 | 36.3 | 2024-02-06 | 46.2 |
| 2024-04-15 | 36.0 | 2024-02-05 | 45.5 |
| 2024-04-12 | 37.2 | 2024-02-02 | 43.6 |
| 2024-04-10 | 38.4 | 2024-02-01 | 43.5 |
| 2024-04-09 | 38.5 | 2024-01-31 | 43.2 |
| 2024-04-08 | 38.0 | 2024-01-30 | 42.6 |
| 2024-04-05 | 37.4 | 2024-01-29 | 42.9 |
| 2024-04-04 | 35.9 | 2024-01-25 | 43.1 |
| 2024-04-03 | 36.0 | 2024-01-24 | 41.1 |
| 2024-04-02 | 36.1 | 2024-01-23 | 40.9 |
| 2024-04-01 | 36.5 | 2024-01-19 | 42.5 |
| 2024-03-28 | 34.8 | 2024-01-18 | 42.9 |
| 2024-03-27 | 35.5 | 2024-01-17 | 42.4 |
| 2024-03-26 | 34.1 | 2024-01-16 | 42.6 |
| 2024-03-22 | 34.4 | 2024-01-15 | 43.7 |
| 2024-03-21 | 34.9 | 2024-01-12 | 45.5 |
| 2024-03-20 | 34.9 | 2024-01-11 | 46.7 |
| 2024-03-19 | 36.2 | 2024-01-10 | 49.0 |
| 2024-03-18 | 37.7 | 2024-01-09 | 49.3 |
| 2024-03-14 | 35.6 | 2024-01-08 | 48.8 |
| 2024-03-13 | 34.9 | 2024-01-05 | 51.3 |
| 2024-03-12 | 36.2 | 2024-01-04 | 53.2 |
| 2024-03-11 | 37.8 | 2024-01-03 | 52.5 |
Concord Drugs Ltd (BOM:538965) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Concord Drugs Ltd
ISIN : INE858L01010
Compare
Compare
Traded in other countries / regions
538965.India IPO Date
2015-02-23Description
Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers